Viewing nowCombinationKVAJET Tablets 10/10 mg
Ezetimibe 10mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Farmgen Science Co., Ltd.

MFDS item code 202004132 · Approved 2020.05.29 · Insurance code 670104890
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps to control cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It lowers total cholesterol, LDL cholesterol, Apolipoprotein B, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol, the good cholesterol, thereby reducing the risk of cardiovascular disease. This medication is used in conjunction with dietary management and is suitable for individuals who do not achieve sufficient results from dietary control alone. Prior to administration, it is important to confirm the presence of other conditions that may cause dyslipidemia, such as diabetes and hypothyroidism. Additionally, it is important to evaluate lipid levels and risk factors of the patient in order to develop a more effective treatment plan. This medication is used to improve hypercholesterolemia and reduce the risk of atherosclerotic vascular disease.
This medicine is administered once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. For patients taking ezetimibe and rosuvastatin concomitantly, switching to this medicine (a combination product with the same amounts of each active ingredient) may be considered for convenience.
This medication may cause a rare side effect known as rhabdomyolysis, which can lead to serious muscle issues; therefore, if symptoms of muscle pain or weakness occur, the doctor must be informed immediately. Additionally, in patients at high risk of serious myopathy or rhabdomyolysis, such as those with severe infections, hypotension, or who have undergone major surgery, administration of this medication should be temporarily suspended or discontinued. This medication should not be administered to patients with poor liver function or active liver disease. Patients with severely impaired kidney function (creatinine clearance < 30 mL/min) should also avoid this medication. Pregnant women or those who may become pregnant, as well as breastfeeding mothers, should not take this medication. This medication contains lactose; therefore, patients with lactose intolerance or related genetic conditions should not take it. Caution is advised while using this medication in patients with a history of alcohol addiction or liver disease, moderate to severe liver dysfunction, and in elderly patients (70 years and older) due to the heightened risk of myopathy. Furthermore, the risk of muscle damage may increase when used in combination with certain other medications, so inform the doctor or pharmacist if other medications are being taken. Regular liver function tests should be performed while taking this medication, and if any signs of liver damage occur, the healthcare provider must be notified immediately. Symptoms such as muscle pain, cramps, weakness, fatigue, fever, etc., should prompt immediate reporting to the doctor, and if necessary, blood tests should be carried out to check for muscle damage. This medication has not been established for safety and efficacy in children, thus it is not recommended. When administering to elderly patients, careful observation is required to consider the risk of myopathy. In the case of overdose, since there is no specific antidote, treatment should be symptomatic, and liver function and muscle enzyme tests should be conducted. Caution is needed while driving or operating machinery since dizziness may occur during the use of this medication. Lastly, this medication should be stored out of reach of children, and it is recommended not to transfer it to another container for safety.
Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevation of ALT, elevation of AST, myalgia, edema, elevated blood bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory tract infection, chest pain, facial edema, strange feeling, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, fatty liver, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, profuse sweating, dermatitis, burning sensation of the skin, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, weakness, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, myalgia, joint pain, increased CK, chest pain, chest discomfort, generalized edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival injection, renal failure, liver function abnormalities, increased serum creatinine, hypertension, increased blood urea, increased CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is between 1 to 30 degrees Celsius (room temperature) to maintain its effectiveness.
White to nearly white round film-coated tablets
30 tablets/box (10 tablets/PTPX3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Farmgen Science Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.